Standard Biotools reported $506.04M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Agilent USD 4.25B 45M Jul/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Bio-Rad Laboratories USD 2.81B 225.5M Jun/2025
Bruker USD 2.16B 51.2M Jun/2025
Danaher USD 11B 1.47B Jun/2025
Illumina USD 2.64B 32M Jun/2025
Myriad Genetics USD 287.2M 10.8M Mar/2025
Nikon Corporation JPY 630.92B 10.7B Jun/2025
Revvity USD 2.24B 81.76M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sony JPY 26.35T 18.89T Jun/2025
Standard Biotools USD 506.04M 130.16M Jun/2025
Thermo Fisher Scientific USD 24.58B 1.21B Jun/2025
Waters USD 1.78B 42.24M Jun/2025